Eight Advisory supported Ampersand Capital Partners in the context of its acquisition of Julius Clinical Research

Eight Advisory supported Ampersand Capital Partners in the context of its acquisition of Julius Clinical Research

Eight Advisory supported Ampersand Capital Partners in the context of its acquisition of Julius Clinical Research, providing financial and tax due diligence services.

The investment and partnership with Ampersand will enable the Julius Clinical Research to expand its scientific and therapeutic expertise as well as build its geographic footprint in Europe and North America to accelerate growth of its CRO services.

 

Julius Clinical Research, founded in 2008 and based in Zeist, The Netherlands, is a scientifically focused CRO providing end-to-end clinical trial service to pharmaceutical and biotechnology customers, as well as governments and academia. Julius Clinical’s renowned scientific leaders are at the forefront of their fields, which combine with operational excellence and a global network of research sites to deliver tailor-made solution for customers and their clinical trials. With a focus on the therapeutic areas of neurology, renal, cardiometabolic and infectious diseases, Julius Clinical has grown to approximately 200 employees and has supported over 130 clinical trials, enrolling more than 200,000 participants in around 40 countries.

 

Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, Massachusetts, and Amsterdam, Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm’s core healthcare sectors.

 

Eight Advisory financial due diligence team consisted of: Hans Bogaardt (Partner), Joris Peers (Director), Fábio Gonçalves Viegas (Manager), Luuk Hintzen (Senior) and Thomas Fleury (Analyst).

 

The tax due diligence team consisted of: Christian Van Craeyvelt (Partner) and Bram de Roo (Manager).

 

Hans

Bogaardt

Partner

Transaction Services

Eight Advisory Amsterdam

Christian

Van Craeyvelt

Partner

Tax

Eight Advisory Brussels

Your message has been sent

Thank you, your application has been sent.

Report request

Similar
Articles

Deals

Eight Advisory supported Clearway Group in its acquisition of Secontec Group

4 Mar 2024

Read more

Deals

Eight Advisory supported Capza on its investment in Bnetwork 

4 Mar 2024

Read more

Articles

Defense Finance: addressing the defense technology financing challenges

4 Mar 2024

Read more

Deals

Eight Advisory supported Activa Capital on its investment in Go! Formations 

29 Feb 2024

Read more

Deals

Eight Advisory supported Strada Partners on its investment in Elsyca 

29 Feb 2024

Read more

All the news

Your message has been sent

Thank you, your application has been sent.

What is the subject of your request?

  • General questions
  • Jobs
  • Information for the press

Specify your request

Choose an office

  • Eight Advisory London

  • Eight Advisory Paris

  • Eight Advisory Rennes

  • Eight Advisory Nantes

  • Eight Advisory Lyon

  • Eight Advisory Marseille

  • Eight Advisory Brussels

  • Eight Advisory Frankfurt

  • Eight Advisory Munich

  • Eight Advisory Hamburg

  • Eight Advisory Zürich

  • Eight Advisory Amsterdam

  • Eight Advisory Köln

  • Eight Advisory Madrid

  • Eight Advisory New York

Application

Unsolicited application

Specify your request